GSK accused of ‘market abuse’ in UK
GlaxoSmithKline is being accused of undertaking unfair ‘pay-for-delay’ delays with several generics firms in the UK over the sale of copycat forms of its drug Seroxat.
Read MoreAuthor: Ben Adams
UK pharma scientist jailed over trial fraud
A UK-based pharma scientist has been sentenced to three months in prison for altering pre-clinical trial data designed to support applications to perform human trials.
Read MoreAZ team up with Oxford Cancer Biomarkers
Oxford Cancer Biomarkers formed a new pact with AstraZeneca for biomarker discovery, with the potential for further collaboration on validation and development of resulting biomarkers.
Read MoreEngland urged on MMR as Welsh epidemic grows
The UK health secretary Jeremy Hunt is advising unprotected children and adults in England to have the MMR vaccine as the measles outbreak in Wales continues unabated.
Read MoreTwo million unaware of asthma attack risk
Asthma UK has revealed new data showing people with asthma “considerably underestimate” their risk of potentially fatal asthma attacks in the UK.
Read More- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
